Target Price | €27.00 |
Price | €21.03 |
Potential | 28.39% |
Number of Estimates | 19 |
19 Analysts have issued a price target Bayer 2026 . The average Bayer target price is €27.00. This is 28.39% higher than the current stock price. The highest price target is €37.00 75.94% , the lowest is €22.00 4.61% . | |
A rating was issued by 21 analysts: 6 Analysts recommend Bayer to buy, 15 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2026 of 28.39% . Most analysts recommend the Bayer stock at Hold. |
16 Analysts have issued a sales forecast Bayer 2025 . The average Bayer sales estimate is €46.4b . This is 0.38% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €47.1b 1.00% , the lowest is €45.7b 1.98% .
This results in the following potential growth metrics:
2024 | €46.6b | 2.16% |
---|---|---|
2025 | €46.4b | 0.38% |
2026 | €47.2b | 1.60% |
2027 | €48.2b | 2.16% |
2028 | €49.3b | 2.22% |
2029 | €50.5b | 2.54% |
16 Analysts have issued an Bayer EBITDA forecast 2025. The average Bayer EBITDA estimate is €9.4b . This is 9.90% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €10.1b 17.50% , the lowest is €8.8b 2.72% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €8.5b | 30.89% |
---|---|---|
2025 | €9.4b | 10.38% |
2026 | €9.9b | 4.79% |
2027 | €10.3b | 4.00% |
2028 | €10.4b | 1.70% |
2029 | €10.5b | 0.88% |
2024 | 18.30% | 29.37% |
---|---|---|
2025 | 20.28% | 10.82% |
2026 | 20.91% | 3.11% |
2027 | 21.29% | 1.82% |
2028 | 21.18% | 0.52% |
2029 | 20.84% | 1.61% |
9 Bayer Analysts have issued a net profit forecast 2025. The average Bayer net profit estimate is €2.0b . This is 177.02% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €3.6b 242.31% , the lowest is €1.3b 151.15% .
This results in the following potential growth metrics and future Net Margins:
2024 | €-2.6b | 13.04% |
---|---|---|
2025 | €2.0b | 177.02% |
2026 | €2.6b | 34.20% |
2027 | €3.0b | 12.83% |
2028 | €3.3b | 11.25% |
2029 | €3.2b | 4.85% |
2024 | -5.48% | 11.12% |
---|---|---|
2025 | 4.24% | 177.36% |
2026 | 5.60% | 32.08% |
2027 | 6.18% | 10.36% |
2028 | 6.73% | 8.90% |
2029 | 6.24% | 7.28% |
9 Analysts have issued a Bayer forecast for earnings per share. The average Bayer EPS is €2.00 . This is 176.92% higher than earnings per share in the financial year 2024. The highest EPS forecast is €3.70 242.31% , the lowest is €1.33 151.15% .
This results in the following potential growth metrics and future valuations:
2024 | €-2.60 | 13.04% |
---|---|---|
2025 | €2.00 | 176.92% |
2026 | €2.69 | 34.50% |
2027 | €3.03 | 12.64% |
2028 | €3.37 | 11.22% |
2029 | €3.21 | 4.75% |
Current | -8.10 | 10.10% |
---|---|---|
2025 | 10.50 | 229.63% |
2026 | 7.83 | 25.43% |
2027 | 6.93 | 11.49% |
2028 | 6.23 | 10.10% |
2029 | 6.55 | 5.14% |
Based on analysts' sales estimates for 2025, the Bayer stock is valued at an EV/Sales of 1.15 and an P/S ratio of 0.45 .
This results in the following potential growth metrics and future valuations:
Current | 1.15 | 10.16% |
---|---|---|
2025 | 1.15 | 0.10% |
2026 | 1.13 | 1.57% |
2027 | 1.11 | 2.11% |
2028 | 1.09 | 2.16% |
2029 | 1.06 | 2.48% |
Current | 0.44 | 20.28% |
---|---|---|
2025 | 0.45 | 0.38% |
2026 | 0.44 | 1.57% |
2027 | 0.43 | 2.12% |
2028 | 0.42 | 2.17% |
2029 | 0.41 | 2.48% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Hold
➜
Hold
|
Unchanged | Apr 06 2025 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Mar 31 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
HSBC |
Hold
➜
Hold
|
Unchanged | Mar 23 2025 |
MWB RESEARCH AG |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Hold
➜
Hold
|
Apr 06 2025 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Mar 31 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 26 2025 |
Unchanged
HSBC:
Hold
➜
Hold
|
Mar 23 2025 |
Unchanged
MWB RESEARCH AG:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.